Related Experiment Video
Updated: Jun 21, 2025

Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration
Published on: May 24, 2024
Etiology-Specific Effects of Impaired Functional Status on Liver Transplant Outcomes
David Uihwan Lee1, Kuntal Bhowmick2, Aldanah Althwanay3
1Division of Gastroenterology and Hepatology, Department of Medicine, University of Maryland School of Medicine, 22 S Greene St, Baltimore, MD, 21201, USA. dvleeman@gmail.com.
Pre-liver transplant functional status significantly impacts outcomes, with metabolic dysfunction-associated steatotic liver disease (MASLD) patients showing worse prognosis. Functional status may not universally predict outcomes for all liver transplant etiologies.
Area of Science:
- Hepatology
- Transplant Surgery
- Clinical Prognostics
Background:
- Pre-liver transplant (LT) functional status is a key prognostic factor.
- Limited data exists on how functional status impacts LT outcomes across diverse liver disease etiologies.
- This study investigates functional status's effect on post-LT prognosis stratified by liver disease type.
Purpose of the Study:
- To evaluate the impact of pre-transplant functional status on post-liver transplant outcomes.
- To stratify liver transplant recipients by etiology of liver disease and assess functional status effects within each subgroup.
- To identify specific liver disease etiologies where functional status is a critical predictor of post-transplant prognosis.
Main Methods:
- Utilized the 2005-2019 UNOS STAR database, including 14,290 liver transplant recipients.
- Stratified patients by functional status using the Karnofsky Performance Scale (KPS): no assistance, some assistance, or total assistance.
- Categorized patients into six etiological groups: MASLD, hereditary disorders, hepatitis C, hepatitis B, autoimmune disease (AID), and alcoholic liver disease (ALD).
Main Results:
- Patients with MASLD requiring assistance (some or total) had significantly higher rates of graft failure and all-cause mortality.
- MASLD patients needing total assistance experienced increased mortality from cardiac, infectious, renal, and respiratory causes, as well as graft rejection.
- Hereditary liver disease recipients needing some assistance showed a lower incidence of all-cause mortality; however, hepatitis C, AID, and ALD recipients with total assistance had higher mortality.
Conclusions:
- Patients with MASLD cirrhosis exhibit the poorest post-transplant outcomes, indicating high vulnerability.
- Poor functional status did not significantly correlate with adverse outcomes in patients with end-stage liver disease from hepatitis B or hereditary causes.
- The Karnofsky Performance Scale (KPS) may have limited applicability across all liver transplant recipient etiological subgroups.
More Related Videos
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

